Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Vliet, H.A.A.M. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(9)
+
-
Availability
Open access
(2)
+
-
Some under embargo
(1)
+
-
Metadata Only
(8)
+
-
Creation Date
2013
(3)
+
-
2010
(2)
+
-
2011
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(10)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(10)
+
-
Author
Vliet, H.A.A.M. van
(11)
+
-
Helmerhorst, F.M.
(9)
+
-
Rosendaal, F.R.
(8)
+
-
Rosing, J.
(7)
+
-
Raps, M.
(6)
+
-
Fleischer, K.
(4)
+
-
Ballieux, B.E.P.B.
(3)
+
-
Stegeman, B.H.
(3)
+
-
Thomassen, S.
(3)
+
-
Hylckama, V.A. van
(2)
+
-
Lopez, L.M.
(2)
+
-
Show more
Language
en
(11)
+
-
Search results
(1 - 11 of 11)
show grid
show list
save search
Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal
Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women
Sex Hormone-Binding Globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal
Quadriphasic versus monophasic oral contraceptives for contraception
Triphasic versus monophasic oral contraceptives for contraception
Hormonal contraceptives : effectiveness and adverse effects
Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis
Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens
Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate